National Bank of Canada’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.75K Buy
237
+32
+16% +$1.15K ﹤0.01% 2472
2026
Q1
$7.24K Buy
205
+2
+1% +$81 ﹤0.01% 2409
2025
Q4
$8.24K Sell
203
-6
-3% -$261 ﹤0.01% 2351
2025
Q3
$9.83K Sell
209
-6
-3% -$311 ﹤0.01% 2326
2025
Q2
$11.2K Buy
215
+44
+26% +$2.42K ﹤0.01% 2323
2025
Q1
$10.3K Buy
+171
New +$11K ﹤0.01% 2241

Other funds holding CNMD

National Bank of Canada's CNMD Position: Q2 2026 in Review

National Bank of Canada increased its CONMED (CNMD) stake by 16% in Q2 2026, buying an estimated $1.15K and bringing the position to 237 shares worth $7.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

National Bank of Canada first reported a position in CNMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.2K in Q2 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • National Bank of Canada held 237 shares of CONMED worth $7.75K as of Q2 2026.
  • National Bank of Canada bought 32 CONMED shares in Q2 2026, an estimated $1.15K.
  • CONMED made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2472 holding.
  • National Bank of Canada first reported a position in CONMED in Q1 2025 and has held it in 6 quarters since.
  • National Bank of Canada's CONMED position peaked at $11.2K in Q2 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.